Pediatric cases of SJS are related more often to infection, whereas adult cases typically are drug or malignancy related. In about 50% of cases, no identifiable cause is found (Parillo & Parillo, 2002) . The drugs most commonly associated with these diseases are anticonvulsants, sulfa preparations, allopurinol, corticosteroids, and nonsteroidal anti-inflammatory drugs (see Figure 1 ).
Symptoms usually appear within the first 14 days of the start of the offending drug therapy (Bankston, Deshotels, & Daughtry, 2001 ). Both conditions also are associated with bacterial and viral infections as well as with malignancies. The literature is very nonspecific regarding the types of malignancies connected with SJS and TEN, but this association may be related to the drugs used to treat specific malignancies or their side effects. Kasper (2001) observed an increased incidence of SJS in patients who were receiving both phenytoin and steroids and who completed whole brain irradiation for brain metastasis. Additional links to anticonvulsants and cranial irradiation are noted in the literature (Cockey, Amann, Reents, & Lynch, 1996; Micali, Linthicum, Han, & West, 1999) .
SJS and TEN are immunologic in origin, but their exact etiology is not known (Patterson & Tripathi, 1999) . Researchers have determined that apoptosis of keratinocytes occurs; this cell destruction is thought to be mediated or triggered by a cytokine, such as tumor necrosis factor. Antigen-antibody immune complexes are formed that trigger cytokine release. CD4 and CD8 T lymphocytes also are present in patients with SJS or TEN ( The use of steroids is controversial. Healthcare professionals always should consider an early transfer to a burn unit for patients with a comorbid condition such as cancer because this action is associated with improved outcomes. Implications for oncology nurses and a case study are presented in this article.
